BrightGene Bio-Medical Technology Co

BrightGene Bio-Medical Technology Co Inventory

The Inventory of BrightGene Bio-Medical Technology Co (688166.SS) as of Nov 22, 2026 is 364.25 M CNY. In the previous year, Inventory was 364.61 M CNY — a change of -0.10% (lower).

Inventory

364.25 MCNY

YoY

-0.10%

Last updated:

Inventory of BrightGene Bio-Medical Technology Co is 2025 364.25 M CNY. Inventory of BrightGene Bio-Medical Technology Co was 2024 364.61 M CNY. It decreases by -0.10% lower compared to the previous year.

The BrightGene Bio-Medical Technology Co Inventory history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Inventory
Date
Inventory
Jan 1, 2018
103.33 M CNY
Jan 1, 2019
136.89 M CNY
Jan 1, 2020
203.20 M CNY
Jan 1, 2021
200.06 M CNY
Jan 1, 2022
280.35 M CNY
Jan 1, 2023
344.63 M CNY
Jan 1, 2024
364.61 M CNY
Jan 1, 2025
364.25 M CNY
The BrightGene Bio-Medical Technology Co Inventory history
YEARInventoryYoY
364.25 MCNY-0.10%
364.61 MCNY+5.80%
344.63 MCNY+22.93%
280.35 MCNY+40.13%
200.06 MCNY-1.55%
203.20 MCNY+48.45%
136.89 MCNY+32.48%
103.33 MCNY+19.87%
86.20 MCNY+35.92%
63.42 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

BrightGene Bio-Medical Technology Co Stock analysis

What does BrightGene Bio-Medical Technology Co do? BrightGene Bio-Medical Technology Co., Ltd. generates revenue by researching, developing, and manufacturing biopharmaceuticals, medicines, and special generic active pharmaceutical ingredients and finished dosage forms. The company's product portfolio centers on antifungal, antiviral, and immunosuppressive APIs, alongside other APIs and preparations. Its generic drug offerings specifically include entecavir, caspofungin, micafungin, posaconazole, everolimus, and fondaparinux sodium. The firm sells these products to customers in both domestic and overseas markets. By leveraging its capabilities in producing essential active pharmaceutical ingredients and finished dosage forms, the company serves the broader pharmaceutical sector through its established manufacturing and research operations. BrightGene Bio-Medical Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about BrightGene Bio-Medical Technology Co stock

Inventory of BrightGene Bio-Medical Technology Co is 364.25 M CNY in 2025.

Inventory of BrightGene Bio-Medical Technology Co changed from 364.61 M CNY to 364.25 M CNY, representing a -0.10% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Inventory BrightGene Bio-Medical Technology Co since 2006 – with annual values, charts, and detailed analysis.

Inventory includes raw materials, work-in-progress, and finished goods. Efficient inventory management is crucial for profitability.

Inventory's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Inventory's BrightGene Bio-Medical Technology Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — BrightGene Bio-Medical Technology Co

All Key Metrics — BrightGene Bio-Medical Technology Co